SCHEMBL24119693

SCHEMBL24119693

CN(CCCNC(=O)C(F)(F)F)C(=O)C(F)(F)F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
POLB P06746 1/20 0.59
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
EPHX1 P07099 1/20 0.53
CA14 Q9ULX7 2/20 0.53
CA3 P07451 2/20 0.52
CA5A P35218 2/20 0.52
CA5B Q9Y2D0 2/20 0.52
CA12 O43570 1/20 0.52
CA2 P00918 1/20 0.52
CA4 P22748 1/20 0.52
CA6 P23280 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
CTSK P43235 3/20 0.42
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9721539 0.83 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL9721443 0.83 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL10230053 0.81 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL12393190 0.80 CTSK (0.46) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL3138315 0.80 CA14 (0.62) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL22688574 0.78 CA14 (0.56) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL15254571 0.78 CA14 (0.52) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL2579949 0.77 CTSK (0.44) CA14CTSKMAPTCHRM2CHRM4
SCHEMBL21761825 0.76 CA3 (0.68) ALDH1A1SMN1; SMN2POLBMEN1KMT2A
SCHEMBL10230055 0.76 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395292-A1 Detection Method for Natural and Modified Small Nucleic Acids ZATA PHARMACEUTICALS, INC. 2021-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395292-A1 Detection Method for Natural and Modified Small Nucleic Acids NCL, POLRMT, NSUN3 ALDH1A1 4651/4885SMN1; SMN2 3008/4885POLB 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.